BUSINESS● LOWAug 12 · Aug 12, 2026, 8:33 PM
Reviva Pharmaceuticals GAAP EPS of -$0.19 beats by $0.17
Seeking Alpha Tech
Reviva Pharmaceuticals reported GAAP EPS of -$0.19, which beat expectations by $0.17. This indicates the company's financial performance exceeded analyst expectations for the period.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoFifth Third expects 2.5%-3.5% Q4 net interest income growth as it targets $200M-$300M buybacksSeeking Alpha TechBUSINESS31m agoServisFirst outlines 5-7 bps quarterly margin expansion as it launches 2m-share repurchase planSeeking Alpha Tech